Ezinapc Ampharco medicine for allergic rhinitis, chronic urticaria (10 blisters x 10 tablets)
Dosage form Box of 10 blisters x 10 tablets
Specifications Cetirizine
Ingredient
| Composition information | Content |
| Cetirizine | 10mg |
Uses
indications
Ezinapc is indicated for treatment in the following cases:
Code ATC: R06AX26
Cetirizin is a powerful antihistamine that has an anti -allergy effect, but does not cause drowsiness at the pharmacological dosage.
Cetirizin has a selective antagonistic effect in H's receptor, and the effect on other receptors is negligible, so there is almost no antagonistic effect acetylcholin and no serotonin antagonistic effect. Cetirizin inhibits the "early" stage of allergic reactions through histamine intermediaries and also reduces the relocation of inflammatory cells and reduces the release of intermediate substances at the "late" stage of allergic reactions.
pharmacokinetics
The drug is absorbed quickly after drinking. The concentration of the equilibrium measurement is 0.3 mcg/ml, achieving the pharmacy after 1.0 + 0.5 hours. Oral bioavailability does not change when taking the drug with food. The volume
the apparent distribution is 0.50 liters/kg. The ratio of binding with plasma proteins is 90 - 96%.
About 2/3 of the dose is exported in the form of unchanged urine. The semi -cancellation time in the plasma of cetirizin is approximately 10 hours. Cetirizin has linear dynamics at the dose of 5-60 mg.
The drug in breast milk, but almost does not go through the bloody barrier.
Before taking Ezinapc Ampharco medicine for allergic rhinitis, chronic urticaria (10 blisters x 10 tablets)
How to use
Ezinapc Ampharco is taken orally, or not with food.
Dosage
Dosage of Ezinapc Ampharco for adults and children aged 6 and older: Take 1 tablet of 10 mg x 1 time/ day.
Ezinapc ampharco dose for patients with liver failure: The dose should be half reduced.
Dosage Ezinapc Ampharco for patients with renal failure: The dose is adjusted according to the CLCR as the following table:
Kidney function
CLCR
(ml/minute)
Dosage
Normal ≥ 80 10 mg x 1 time/day
50-79
10 mg x 1 time/day
Moderate kidney failure
30-49
5 mg x 1 time/day
5 mg every 2 days
What to do when overdose?
Symptoms of ezinapc overdose are: Sleeping in adults, in children may be agitated.
Serious overdose should cause vomiting and gastric lavage along with supportive methods. Up to now, there is no specific antidote.
Hemorrhage is not effective in treating overdose of Cetirizin.
What to do when you forget 1 dose?
If you forget to use the drug, take that dose as soon as you remember. Ignore the forgotten dose if the time to remember is close to the next dose. Do not take additional pills in the next dose to compensate for the forgotten dose.
Side Effects
Common (ADR> 1/100)
The most common is the phenomenon of chicken sleep. The ratio of ADR depends on the dose.
In addition, the drug also causes fatigue, dry mouth, sore throat, dizziness, headache, nausea.
Less (1/1000 Anorexia or increased appetite, urinary retention, flushing, increasing salivation. Rare (ADR Hemorrhagic anemia, thrombocytopenia, severe hypotension, anaphylaxis, hepatitis, cholestasis, glomerulonephritis.
Warnings
Contraindicated
Contraindicated treatment with Ezinapc in the following cases:
Precautions when using
affects the ability to drive and operate machinery
In some patients using Cetirizin have a chicken sleep, so be cautious when driving, or operating machinery when using Cetirizin.
time pregnancy
Although Cetirizin does not cause teratogenicity in animals, there is no adequate studies on pregnant people, so do not use drugs during pregnancy.
period for breastfeeding
Cetirizin is excreted in milk, so avoid breastfeeding when the mother uses the medication.
Drug interaction
Concentration of this medication with alcohol or other central neurological inhibitors may increase the effects of these drugs.
Cetirizin clearance is slightly reduced when taken with 400mg Theophyllin.
Storage
The drug needs to be stored at temperatures below 30ºC, avoid direct light and wet place.
Other drugs
- EPIVAL CR 500MG PROLONGED-RELEASE TABLETS
- EPANUTIN 100MG CAPSULES
- GLYFORMIN / METFORMIN
- PANADOL SOLUBLE 500 MG TABLETS
- ROWATINEX CAPSULES
- SMOFKABIVEN PERIPHERAL EMULSION FOR INFUSION
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions